Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tianjin Medical University Cancer Institute and Hospital
Massachusetts General Hospital
M.D. Anderson Cancer Center
Insel Gruppe AG, University Hospital Bern
University of Kentucky
Sanford Health
Centre Antoine Lacassagne
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Groupe Oncologie Radiotherapie Tete et Cou
Memorial Sloan Kettering Cancer Center
GERCOR - Multidisciplinary Oncology Cooperative Group
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Pittsburgh
West China Hospital
Groupe Oncologie Radiotherapie Tete et Cou
Thomas Jefferson University
Beijing Tongren Hospital
University of Texas Southwestern Medical Center
Biotech Pharmaceutical Co., Ltd.
Fudan University
City of Hope Medical Center
Institut du Cancer de Montpellier - Val d'Aurelle
The Netherlands Cancer Institute
Beijing Tongren Hospital
Sun Yat-sen University
UNC Lineberger Comprehensive Cancer Center
Hunan Cancer Hospital
Washington University School of Medicine
UNC Lineberger Comprehensive Cancer Center
Institute of Oncology Ljubljana
University of Cincinnati
University of Missouri-Columbia
University College, London
UNC Lineberger Comprehensive Cancer Center
Shanghai Jiao Tong University School of Medicine
The University of Texas Health Science Center at San Antonio
Stanford University
Vanderbilt-Ingram Cancer Center
National Cancer Institute, Naples
Emory University
George Washington University
Assistance Publique Hopitaux De Marseille
National Cancer Centre, Singapore